Standard and Hypofractionated Dose Escalation to Intraprostatic Tumour Nodules in Localized Prostate Cancer
This journal activity, Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE Trial, provides practitioners with information on the side effects and efficacy associated with the use
Category
  • Genitourinary Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Genomic Classifiers in Personalized Prostate Cancer Radiotherapy Approaches
This journal activity provides practitioners with a comprehensive review of the data to date, as well as expert opinions, on the incorporation of genomic classifiers into prostate cancer risk stratification in clinical practice as well as future translational directions.
Category
  • Genitourinary Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Considerations for Treatment of PSMA-Staged High-Risk Patients in Community Practice
This activity discusses the use of PSMA PET for staging in high-risk prostate cancer. This includes when to order a PSMA PET, how to interpret it, common pitfalls and controversies of the scans.
Category
  • Other
  • Genitourinary Cancer
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance